4D Molecular Therapeutics’ (FDMT) Sell (E+) Rating Reiterated at Weiss Ratings
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report)‘s stock had its “sell (e+)” rating reiterated by Weiss Ratings in a research note issued to investors on Saturday,Weiss Ratings reports. A number of other equities research analysts have also recently weighed in on the stock. Morgan Stanley cut their price objective on shares of 4D Molecular […]
4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report)‘s stock had its “sell (e+)” rating reiterated by Weiss Ratings in a research note issued to investors on Saturday,Weiss Ratings reports. A number of other equities research analysts have also recently weighed in on the stock. Morgan Stanley cut their price objective on shares of 4D Molecular […]
